List of articles with "Keymed Biosciences"

Stapokibart Study Published

Stapokibart Study Published

China Chengdu Keymed Biosciences Stapokibart Nature Medicine
Stapokibart Phase-III Breakthrough

Stapokibart Phase-III Breakthrough

China Chengdu Keymed Biosciences Stapokibart IL-4Rα Antibody
Stapokibart Revolutionizes Allergy Treatment

Stapokibart Revolutionizes Allergy Treatment

China Chengdu Keymed Biosciences Stapokibart Nature Medicine
Stapokibart Breakthrough

Stapokibart Breakthrough

China Chengdu Keymed Biosciences Stapokibart IL-4Rα
Keymed Biosciences 2024 Results

Keymed Biosciences 2024 Results

China Chengdu Keymed Biosciences Stapokibart CM310
Stapokibart Approval!

Stapokibart Approval!

China Chengdu Keymed Biosciences Stapokibart IL-4Rα
Keymed's Stapokibart Approval

Keymed's Stapokibart Approval

China Chengdu Keymed Biosciences Stapokibart NMPA
Stapokibart Approved!

Stapokibart Approved!

China Chengdu Keymed Biosciences Stapokibart Allergic Rhinitis
Stapokibart Approval

Stapokibart Approval

China Chengdu Keymed Biosciences Stapokibart Kangyueda
Timberlyne's $180M Launch

Timberlyne's $180M Launch

United States San Diego Keymed Biosciences CM313 Timberlyne
Approval for Stapokibart

Approval for Stapokibart

China Chengdu Keymed Biosciences Stapokibart Kangyueda
Stapokibart Approval

Stapokibart Approval

China Chengdu Keymed Biosciences Stapokibart Kangyueda
Stapokibart Approval

Stapokibart Approval

China Chengdu Keymed Biosciences Stapokibart Chronic Rhinosinusitis
Approval for Stapokibart

Approval for Stapokibart

China Chengdu Keymed Biosciences Stapokibart Chronic Rhinosinusitis
Keymed's Stapokibart Approval

Keymed's Stapokibart Approval

China Chengdu Keymed Biosciences Stapokibart Chronic Rhinosinusitis

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.